Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite

Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost

By McLachlan S-A.   Pintilie M.   Tannock I.F.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 213-223

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel: response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer

By Archer C.D.   Lowdell C.   Sinnett H.D.   English J.   Khan S.   Coombes R.C.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 816-819

Elsevier

Access to resources Recommend Favorite

Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands

By Mol Linda   Koopman Miriam   van Gils Chantal W. M.   Ottevanger Petronella B.   Punt Cornelis J. A.  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 950-955

Informa Healthcare

Access to resources Recommend Favorite

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials

By Atalay G.   Biganzoli L.   Renard F.   Paridaens R.   Cufer T.   Coleman R.   Calvert A.H.   Gamucci T.   Minisini A.   Therasse P.   Piccart M.J.   on behalf of the EORTC Breast Cancer and Early Clinical Studies Groups  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2439-2449

Elsevier

Access to resources Recommend Favorite